Association of Chlamydia pneumoniae and multiple sclerosis: Stage two?
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
“All truth passes through three stages. First, it is ridiculed. Second, it is violently opposed. Third, it is accepted as being self-evident.” Arthur Schopenhauer (1788–1860)
Associations of environmental agents and MS have gone through the first and second stages of Schopenhauer’s “truth” but have not yet attained the stage of acceptance. For more than 50 years environmental triggers, typically viruses, have been implicated in the etiology of MS.1,2⇓ The epidemiology of MS supports an environmental agent. There is evidence of MS clustering,3 and MS increases in incidence with distance in either direction from the equator. Migration away from high prevalence areas before adulthood decreases the likelihood of developing MS. In addition, genetic factors alone are insufficient to cause MS. Despite a clear genetic influence in MS (the rate of concordance is eight times greater in monozygotic than dizygotic twins),4,5⇓ the concordance rate among monozygotic twins remains only 25%. An increased risk of MS has also been observed in persons developing childhood infections as adults.1 Demyelinating animal models exist in which viruses with long incubation periods cause relapsing neurologic disorders,1,6⇓ some of which are immune-mediated. Similar immune reactivities to a number of viruses have been reported in patients with MS.7 Increased antibody titers to a variety of infectious agents …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Deborah Friedman and Dr. Stacy Smith
► Watch
Related Articles
Alert Me
Recommended articles
-
Articles
CSF oligoclonal bands in MS include antibodies against Chlamydophila antigensSong-Yi Yao, Charles W. Stratton, William M. Mitchell et al.Neurology, May 08, 2001 -
Article
Effects of natalizumab therapy on intrathecal antiviral antibody responses in MSFabienne Largey, Ivan Jelcic, Mireia Sospedra et al.Neurology: Neuroimmunology & Neuroinflammation, September 25, 2019 -
Articles
Intrathecal EBV antibodies are part of the polyspecific immune response in multiple sclerosisC. Otto, A. Oltmann, A. Stein et al.Neurology, April 11, 2011 -
Brief Communications
Chlamydia pneumoniae in children with MSFrequency and quantity of intrathecal antibodiesK. Rostasy, H. Reiber, D. Pohl et al.Neurology, July 08, 2003